Category: Immunology | FAU https://www.fau.eu Mon, 07 Sep 2026 09:12:23 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.3 https://www.fau.eu/wp-content/uploads/sites/6/2025/11/cropped-cropped-Favicon_BGblue-32x32.png Category: Immunology | FAU https://www.fau.eu 32 32 Rare neurological autoimmune disorder: MLC1 antibody identified as possible trigger https://www.fau.eu/2026/09/news/research/rare-neurological-autoimmune-disorder-mlc1-antibody-identified-as-possible-trigger/ Mon, 07 Sep 2026 09:12:22 +0000 https://www.fau.eu/?p=19790047 NMOSD is an inflammatory autoimmune disorder that damages support and supply cells in the central nervous system, known as astrocytes. Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Uniklinikum Erlangen, LMU University Hospital Munich, the Medical University of Vienna and other international research institutions have now identified an auto-antibody that might be…

Source

]]>
Pregnancy after CAR T-cell therapy https://www.fau.eu/2026/07/news/research/pregnancy-after-car-t-cell-therapy/ Thu, 30 Jul 2026 07:22:43 +0000 https://www.fau.eu/?p=19788606 Autoimmune diseases such as systemic lupus erythematosus mainly affect young women, often in a phase of their lives where they would like to have children. The diseases themselves or the immunosuppressive drugs required to treat them make pregnancy difficult or can even make it temporarily impossible to get pregnant. CAR T-cell therapy can provide a decisive advantage for these young women…

Source

]]>
New approach to combat rejection after stem cell transplantation https://www.fau.eu/2026/05/news/ai-assisted-project-investigating-the-connection-between-bowel-disease-and-parkinsons/ Thu, 07 May 2026 07:45:00 +0000 https://www.fau.eu/?p=19779952 The National Center for Tumor Diseases (NCT) is funding the multicenter CURE-GvHD study, led by Uniklinikum Erlangen, with €2.5 million from the Federal Ministry of Research, Technology, and Space. A CAR-T cell approach is being evaluated for patients with severe chronic graft-versus-host disease (cGvHD). Allogeneic blood stem cell transplantation, the transfer of donated stem cells…

Source

]]>
Why our immune system remembers vaccinations for decades https://www.fau.eu/2026/02/news/why-our-immune-system-remembers-vaccinations-for-decades/ Tue, 24 Feb 2026 10:00:00 +0000 https://www.fau.eu/?p=19770259 Why can the human immune system often remember a vaccination for a whole lifetime? Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen have now investigated this question. Their study provides a surprisingly clear answer: The immune cells responsible for immunological memory seem to switch to a type of standby mode at an early stage.

Source

]]>
Blood test to give insights into a person’s infection history https://www.fau.eu/2026/01/news/blood-test-to-give-insights-into-a-persons-infection-history/ Fri, 30 Jan 2026 09:22:00 +0000 https://www.fau.eu/?p=19766257 Which infections have you already come into contact with? In the future, a simple blood test may be all you need to answer that question. Researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen intend to investigate the sensors the immune system uses to identify pathogens. The project is to receive approximately 1.5 million euros in funding from…

Source

]]>
Hope for people with severe autoimmune diseases thanks to cell therapy in Erlangen https://www.fau.eu/2026/01/news/hope-for-people-with-severe-autoimmune-diseases-thanks-to-cell-therapy-in-erlangen/ Tue, 20 Jan 2026 07:48:49 +0000 https://www.fau.eu/?p=19764432 For many people with severe autoimmune diseases, everyday life is marked by pain, exhaustion and taking medication in the long term. Diseases such as systemic lupus erythematosus, systemic sclerosis or autoimmune inflammatory muscle disease are usually lifelong conditions. The results of what is so far the largest study in the world on treating autoimmune diseases with CAR-T cells…

Source

]]>
Killer cells How the immune system selects its defense troops https://www.fau.eu/2025/10/news/research/killerzellen-wie-das-immunsystem-seine-abwehrtruppen-auswaehlt/ Thu, 09 Oct 2025 22:00:31 +0000 https://www.fau.eu/?p=4688726 If killer cells from the immune system encounter signs of an infection, some of them start to divide rapidly. They grow to become a large defense troop that then attacks the pathogen. However, that is not the case for each individual killer cell by any means. Which criteria determine whether cells multiply or not? Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)…

Source

]]>
CAR-T cell therapy treats severe bowel disease successfully for the first time https://www.fau.eu/2025/10/news/research/car-t-zell-therapie-erstmals-bei-schwerer-darmerkrankung-erfolgreich/ Mon, 06 Oct 2025 22:00:37 +0000 https://www.fau.eu/?p=4675700 A team of doctors from Deutsches Zentrum Immuntherapie at Uniklinikum Erlangen has succeeded for the first time in treating a young patient with a severe case of therapy-resistant inflammatory bowel disease (ulcerative colitis) with cell therapy using CD19-CAR-T cells. The results of this innovative treatment have been published in the latest issue of the New England Journal of Medicine.

Source

]]>
CAR-T cells: Gaining a better understanding of treating Lupus disease https://www.fau.eu/2025/03/news/research/car-t-cells-gaining-a-better-understanding-of-treating-lupus-disease/ Thu, 20 Mar 2025 14:05:08 +0000 https://www.fau.eu/?p=3969459 Uniklinikum Erlangen at Friedrich-Alexander-Universität Erlangen-Nürnberg has successfully treated more than 45 people with autoimmune diseases using a novel innovative therapy using CAR-T cells since 2021, including more than 15 patients with systemic lupus erythematosus. The patients, for whom no other treatments were successful, show no symptoms today. In a new study, Professor Dr.

Source

]]>
Hugely significant results for immunotherapy https://www.fau.eu/2024/07/news/hugely-significant-results-for-immunotherapy/ Mon, 15 Jul 2024 22:00:25 +0000 https://www.fau.eu/?p=2853516 Modern cancer immune therapies use the human immune system to fight cancer. Immune cells, in particular T cells, must be trained to recognize cancer cells and target them specifically. The team led by the physicist Prof. Dr. Julio Vera-González in the Laboratory of Systems Tumor Immunology at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) is working together with researchers from Erlangen…

Source

]]>
World’s first CAR-T cell therapy for a child with lupus https://www.fau.eu/2024/07/news/research/worlds-first-car-t-cell-therapy-for-a-child-with-lupus/ Sun, 07 Jul 2024 22:00:02 +0000 https://www.fau.eu/?p=2798050 “One year after the treatment, I feel as good as I did before my diagnosis, except for a few colds,” says Uresa A. today. In June 2023, Uresa (who was 15 years old at the time) received CAR-T cells at Universitätsklinikum Erlangen. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which is a serious autoimmune disease that was attacking Uresa’s body and suddenly…

Source

]]>